Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
47,898,935
-
Number of holders
-
176
-
Total 13F shares, excl. options
-
53,401,411
-
Shares change
-
-350,042
-
Total reported value, excl. options
-
$2,208,658,190
-
Value change
-
-$15,026,392
-
Number of buys
-
80
-
Number of sells
-
-83
-
Price
-
$41.36
Significant Holders of HAEMONETICS CORP - Common Stock (HAE) as of Q2 2015
188 filings reported holding HAE - HAEMONETICS CORP - Common Stock as of Q2 2015.
HAEMONETICS CORP - Common Stock (HAE) has 176 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53,401,411 shares
.
Largest 10 shareholders include Neuberger Berman Group LLC (4,150,626 shares), VANGUARD GROUP INC (3,760,148 shares), BlackRock Fund Advisors (3,019,800 shares), WELLS FARGO & COMPANY/MN (2,352,495 shares), BARROW HANLEY MEWHINNEY & STRAUSS LLC (2,336,063 shares), FMR LLC (2,276,602 shares), WESTWOOD HOLDINGS GROUP INC (2,077,784 shares), PRICE T ROWE ASSOCIATES INC /MD/ (1,799,200 shares), WELLINGTON MANAGEMENT GROUP LLP (1,732,384 shares), and Black Creek Investment Management Inc. (1,654,614 shares).
This table shows the top 176 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.